Data from the Hong Kong Stock Exchange reveals that on August 11, JPMorgan reduced its holdings in PHARMARON (03759) by 953,266 shares, with an average price of HK$29.3257 per share, totaling approximately HK$27.9552 million.
Following the reduction, JPMorgan's latest shareholding in PHARMARON stands at about 28,122,300 shares, representing 7.81% of the total issued shares.